Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0001-9109-5196Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Ismail Mustafa Meraz, Shuhong Wu, Yi Xu…·Jack A. Roth
This study identifies PI3K-mTOR pathway inhibition as a strategy to overcome acquired resistance to KRASG12C inhibitors in NSCLC by targeting 4E-BP1.
Yawen Wang, Ismail Mustafa Meraz, Md Qudratullah…·Yonathan Lissanu
This study shows that SMARCA4 mutations in lung cancer disrupt enhancer landscapes and innate immune gene expression, leading to immunotherapy resistance.
Ismail Mustafa Meraz, Mourad Majidi, Renduo Song…·Jack A. Roth
This study shows NPRL2 gene therapy reduces lung metastases in KRAS/STK11 mutant NSCLC in humanized mice by enhancing immune cell infiltration and reducing T cell inhibitory signals.